Ledger.Open graph →
SEC Form D · filed August 19, 2019

TITAN PHARMACEUTICALS INC

Offering
$2.1M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Sean Corman · Hamilton, NJDirectorJonathan A. Bain · George Town, Cayman IslandsDirectorRajinder A. Kumar · South San Francisco, CADirectorMartin Laidlaw · Grand Cayman, Cayman IslandsDirectorKatherine Beebe · South San Francisco, CAExecErik Torenberg · Walnut, CADirectorAndreas Roell · San Diego, CAExec · DirectorCharles Cayias · VANCOUVER, British Columbia, CanadaDirectorR.Hall Risk · Vancouver, British Columbia, CanadaDirectorRyan Johnson · Westminster, COExec · DirectorSahil Patel · STEWARTSVILLE, NJExecSrihari R. Gandra · Irving, TXDirectorGary Oakley · Grand Cayman, Cayman IslandsDirectorChristopher Panos · VANCOUVER, British Columbia, CanadaExecNimish Bhatt · SANTA FE, NMExec · DirectorIkro Yoon · Miami, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗